NY A07928 | 2021-2022 | General Assembly

Status

Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on June 1 2021 - 25% progression, died in committee
Action: 2022-01-05 - referred to health
Pending: Assembly Health Committee
Text: Latest bill text (Introduced) [HTML]

Summary

Establishes the psychedelic research institute and the psychedelic substances therapeutic research program which shall study and provide recommendations regarding the use of psychedelic substances in the treatment of addictive disorders, depression, post-traumatic stress disorder, end-of-life anxiety and other pertinent outcomes.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Establishes the psychedelic research institute and the psychedelic substances therapeutic research program which shall study and provide recommendations regarding the use of psychedelic substances in the treatment of addictive disorders, depression, post-traumatic stress disorder, end-of-life anxiety and other pertinent outcomes.

Sponsors


History

DateChamberAction
2022-01-05Assemblyreferred to health
2021-06-01Assemblyreferred to health

New York State Sources


Bill Comments

feedback